VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1564642
Sex: F
Age: 46
State: KY

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: back pain has gotten worse; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain has gotten worse) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. Concomitant products included IBUPROFEN for Back pain. On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced BACK PAIN (back pain has gotten worse). At the time of the report, BACK PAIN (back pain has gotten worse) outcome was unknown. Concomitant medications were not provided by reporter.

Other Meds: IBUPROFEN

Current Illness:

ID: 1564643
Sex: F
Age: 42
State: FL

Vax Date: 03/05/2021
Onset Date: 03/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: red numbness; tingling on little toe; red; swelling of breast; lots of discomfort; swelling of hands; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red), BREAST SWELLING (swelling of breast), DISCOMFORT (lots of discomfort), PERIPHERAL SWELLING (swelling of hands) and HYPOAESTHESIA (red numbness) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Breast cancer. On 05-Mar-2021 at 6:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced ERYTHEMA (red), BREAST SWELLING (swelling of breast), DISCOMFORT (lots of discomfort) and PERIPHERAL SWELLING (swelling of hands). On 07-Mar-2021, the patient experienced HYPOAESTHESIA (red numbness) and PARAESTHESIA (tingling on little toe). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, ERYTHEMA (red), BREAST SWELLING (swelling of breast), DISCOMFORT (lots of discomfort), PERIPHERAL SWELLING (swelling of hands), HYPOAESTHESIA (red numbness) and PARAESTHESIA (tingling on little toe) outcome was unknown. It was reported that patient had immune issue . No concomitant medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Added facility information.Updated patient demographics, batch number and re-challenge field.

Other Meds:

Current Illness: Breast cancer

ID: 1564644
Sex: F
Age: 55
State: CA

Vax Date: 03/08/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Difficulty walking; Chills; Joint on her leg has been hurting; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Difficulty walking), CHILLS (Chills) and ARTHRALGIA (Joint on her leg has been hurting) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. No Medical History information was reported. On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced GAIT DISTURBANCE (Difficulty walking), CHILLS (Chills) and ARTHRALGIA (Joint on her leg has been hurting). The patient was treated with PARACETAMOL (TYLENOL) at a dose of unknown. At the time of the report, GAIT DISTURBANCE (Difficulty walking), CHILLS (Chills) and ARTHRALGIA (Joint on her leg has been hurting) outcome was unknown. Patient was taking other medication. No treatment medication information was provided. Action taken with mRNA-1273 in response to the drug was not applicable.

Other Meds:

Current Illness:

ID: 1564645
Sex: M
Age: 90
State: FL

Vax Date: 03/09/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Pain; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain) and SWELLING (Swelling) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain) and SWELLING (Swelling). At the time of the report, PAIN IN EXTREMITY (Pain) and SWELLING (Swelling) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1564646
Sex: M
Age: 72
State: NC

Vax Date: 02/12/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Developed shingles on left side of body and on his back; A regulatory report was received from a Consumer concerning a 72 years old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and developed shingles on the left side of body and on his back (Herpes zoster). The patient's medical history includes numerous medical issues and leukemia for 16 years. The relevant concomitant medications reported were also not provided. On 12 Feb 2021, prior to the onset of the event, the patient received his first dose of two planned vaccine doses of mRNA (Lot number: 031620A) through intramuscular route for prophylaxis of COVID-19 infection. On 04 Mar 2021, patient developed shingles on the left side of body and on his back. The patient was taken to the clinic and was treated with Famvir 500 mg TID and Cortisone Cream. No laboratory data was provided. Action taken with mRNA-1273 in response to the event was not reported. The outcome of the event, developed shingles on left side of body and on his back, was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. However, the patient's underlying medical history of leukemia seems to be a strong confounding factor to the reported event.

Other Meds:

Current Illness: Leukemia

ID: 1564647
Sex: M
Age: 72
State: IN

Vax Date: 02/09/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: achy; nauseated, thought he was going to throw up; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (achy) and NAUSEA (nauseated, thought he was going to throw up) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced MYALGIA (achy) and NAUSEA (nauseated, thought he was going to throw up). At the time of the report, MYALGIA (achy) and NAUSEA (nauseated, thought he was going to throw up) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1564648
Sex: F
Age: 72
State: AZ

Vax Date: 02/24/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: probably cellulitis; Arm Redness; Pain; Swollen arm; Itchy; Warm to touch; had the reaction at the injection site: swollen, red, itchy and very tender to touch; Injection site very tender to touch; Injection site swollen; Injection site redness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CELLULITIS (probably cellulitis), ERYTHEMA (Arm Redness), PAIN (Pain), PERIPHERAL SWELLING (Swollen arm) and PRURITUS (Itchy) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced ERYTHEMA (Arm Redness), PAIN (Pain), PERIPHERAL SWELLING (Swollen arm), PRURITUS (Itchy), SKIN WARM (Warm to touch), VACCINATION SITE PRURITUS (had the reaction at the injection site: swollen, red, itchy and very tender to touch), INJECTION SITE PAIN (Injection site very tender to touch), INJECTION SITE SWELLING (Injection site swollen) and INJECTION SITE ERYTHEMA (Injection site redness). On an unknown date, the patient experienced CELLULITIS (probably cellulitis). The patient was treated with CEFDINIR ongoing from March 2021 for Cellulitis, at a dose of 1 dosage form twice a day. At the time of the report, CELLULITIS (probably cellulitis), ERYTHEMA (Arm Redness), PAIN (Pain), PERIPHERAL SWELLING (Swollen arm), PRURITUS (Itchy), SKIN WARM (Warm to touch), VACCINATION SITE PRURITUS (had the reaction at the injection site: swollen, red, itchy and very tender to touch), INJECTION SITE PAIN (Injection site very tender to touch), INJECTION SITE SWELLING (Injection site swollen) and INJECTION SITE ERYTHEMA (Injection site redness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications included unspecified hormonal medication and thyroid medication. Most recent FOLLOW-UP information incorporated above includes: On 10-Mar-2021: Initial additional

Other Meds:

Current Illness:

ID: 1564649
Sex: F
Age: 28
State: WA

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Itching and swelling on the injection site (looking like a bug bite); Itching and swelling on the injection site (looking like a bug bite); Hardness on the injection site on her right upper arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Hardness on the injection site on her right upper arm), VACCINATION SITE PRURITUS (Itching and swelling on the injection site (looking like a bug bite)) and VACCINATION SITE SWELLING (Itching and swelling on the injection site (looking like a bug bite)) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE INDURATION (Hardness on the injection site on her right upper arm). On 09-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching and swelling on the injection site (looking like a bug bite)) and VACCINATION SITE SWELLING (Itching and swelling on the injection site (looking like a bug bite)). At the time of the report, VACCINATION SITE INDURATION (Hardness on the injection site on her right upper arm), VACCINATION SITE PRURITUS (Itching and swelling on the injection site (looking like a bug bite)) and VACCINATION SITE SWELLING (Itching and swelling on the injection site (looking like a bug bite)) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications included an unspecified asthma inhaler. Treatment for the events included antihistamine.

Other Meds:

Current Illness:

ID: 1564650
Sex: M
Age:
State: MO

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: arm numbness; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (arm numbness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced HYPOAESTHESIA (arm numbness). At the time of the report, HYPOAESTHESIA (arm numbness) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1564651
Sex: M
Age:
State: FL

Vax Date: 02/13/2021
Onset Date: 02/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Arthritis pain, Join pain, Bone pain; Arthritis pain, Join pain, Bone pain; This spontaneous case was reported by a patient family member or friend and describes the occurrence of BONE PAIN (Arthritis pain, Join pain, Bone pain) and ARTHRALGIA (Arthritis pain, Join pain, Bone pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (doxazosin? doxacosin, lisinopril, statin, and ace inhibitors.), Egg allergy and Dairy intolerance. Concomitant products included ACEBUTOLOL HYDROCHLORIDE (SECTRAL), HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE AND HYDROCHLOROTHIAZIDE), LOSARTAN, CELECOXIB (CELEXA [CELECOXIB]) and OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced BONE PAIN (Arthritis pain, Join pain, Bone pain) and ARTHRALGIA (Arthritis pain, Join pain, Bone pain). The patient was treated with SULINDAC ongoing from 26-Feb-2021 for Arthritis, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and SULINDAC on 26-Feb-2021 at an unspecified dose and frequency. At the time of the report, BONE PAIN (Arthritis pain, Join pain, Bone pain) and ARTHRALGIA (Arthritis pain, Join pain, Bone pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: SECTRAL; TRIAMTERENE AND HYDROCHLOROTHIAZIDE; LOSARTAN; CELEXA [CELECOXIB]; PRILOSEC [OMEPRAZOLE MAGNESIUM]

Current Illness: Dairy intolerance; Drug allergy (doxazosin? doxacosin, lisinopril, statin, and ace inhibitors.); Egg allergy

ID: 1564652
Sex: F
Age: 57
State: AZ

Vax Date: 12/23/2020
Onset Date: 01/28/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: feet were warm; rapid test came back positive; felt very tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (feet were warm), SARS-COV-2 TEST POSITIVE (rapid test came back positive) and FATIGUE (felt very tired) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041220A and 011J20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced FEELING HOT (feet were warm), SARS-COV-2 TEST POSITIVE (rapid test came back positive) and FATIGUE (felt very tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 29-Jan-2021, FEELING HOT (feet were warm) and FATIGUE (felt very tired) had resolved. At the time of the report, SARS-COV-2 TEST POSITIVE (rapid test came back positive) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, SARS-CoV-2 test: positive (Positive) positive. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication details was reported. No treatment medication details was reported.

Other Meds:

Current Illness:

ID: 1564653
Sex: F
Age:
State: FL

Vax Date: 03/02/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Extreme fatigue; chills; nausea; vomiting; soreness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extreme fatigue), CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting) and PAIN (soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Extreme fatigue), CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting) and PAIN (soreness). At the time of the report, FATIGUE (Extreme fatigue), CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting) and PAIN (soreness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This case was linked to MOD-2021-057805 (Patient Link). Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1564654
Sex: M
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Delayed side effects; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Delayed side effects) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Delayed side effects). At the time of the report, ADVERSE REACTION (Delayed side effects) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medications were provided No Treatment information provided Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1564655
Sex: F
Age: 70
State: OH

Vax Date: 03/04/2021
Onset Date: 03/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Itch at site of injection; Sore arm; Swelling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itch at site of injection), MYALGIA (Sore arm) and VACCINATION SITE SWELLING (Swelling at injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. No Medical History information was reported. On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itch at site of injection), MYALGIA (Sore arm) and VACCINATION SITE SWELLING (Swelling at injection site). On 08-Mar-2021, VACCINATION SITE PRURITUS (Itch at site of injection), MYALGIA (Sore arm) and VACCINATION SITE SWELLING (Swelling at injection site) had resolved. No concomitant medication details was reported. No treatment medication details was reported.

Other Meds:

Current Illness:

ID: 1564656
Sex: F
Age: 68
State: NY

Vax Date: 02/10/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: low grade fever of 99.9; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low grade fever of 99.9) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). Concomitant products included VALSARTAN, LEVOTHYROXINE SODIUM (SYNTHROID) and ALPRAZOLAM for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PYREXIA (low grade fever of 99.9). In March 2021, PYREXIA (low grade fever of 99.9) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, Body temperature: 99.9. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medication details was reported.

Other Meds: VALSARTAN; SYNTHROID; ALPRAZOLAM

Current Illness:

ID: 1564657
Sex: F
Age: 63
State: AZ

Vax Date: 03/04/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: headache; sore arm at injection site; severe shortness of breath; skin on her entire left palm was peeling; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (severe shortness of breath), SKIN EXFOLIATION (skin on her entire left palm was peeling), VACCINATION SITE PAIN (sore arm at injection site) and HEADACHE (headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The patient's past medical history included Diabetic. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), LISINOPRIL, METFORMIN, GLIPIZIDE, PIOGLITAZONE HYDROCHLORIDE (ACTOS), EZETIMIBE (ZETIA), FAMOTIDINE and ACETYLSALICYLIC ACID (ASPIRIN LOW) for an unknown indication. On 04-Mar-2021 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (sore arm at injection site). In March 2021, the patient experienced DYSPNOEA (severe shortness of breath). March 2021, the patient experienced SKIN EXFOLIATION (skin on her entire left palm was peeling). On an unknown date, the patient experienced HEADACHE (headache). In March 2021, DYSPNOEA (severe shortness of breath) had resolved. At the time of the report, SKIN EXFOLIATION (skin on her entire left palm was peeling), VACCINATION SITE PAIN (sore arm at injection site) and HEADACHE (headache) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Oxygen saturation: 95 (Inconclusive) 95. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. At 10:00 AM the patient felt almost normal from barely breathing, but did end up borrowing her neighbors pulse oximeter where she saw that was at 95%. The patient stated that on the right arm a little spot that was smaller than a pencil eraser that was starting to peel. The patient stated that she did not know how many layers peeled off but it did not hurt or bleed, and it was just her palm. No treatment information was provided.

Other Meds: SYNTHROID; LISINOPRIL; METFORMIN; GLIPIZIDE; ACTOS; ZETIA; FAMOTIDINE; ASPIRIN LOW

Current Illness:

ID: 1564658
Sex: M
Age:
State: CA

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Felt cold; Had a temperature; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Felt cold) and PYREXIA (Had a temperature) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013m20a) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure. On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced NASOPHARYNGITIS (Felt cold) and PYREXIA (Had a temperature). At the time of the report, NASOPHARYNGITIS (Felt cold) and PYREXIA (Had a temperature) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided. Upon internal review on 21-May-2021, the age was corrected to unknown.

Other Meds:

Current Illness: Blood pressure

ID: 1564659
Sex: F
Age: 84
State: OH

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 23Jan2021 and 2nd dose on 05 Mar 2021), ILLNESS (felt sick), HEADACHE (headache), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. . Concomitant products included LISINOPRIL, HCTZ, FENOFIBRATE, VITAMIN and MAGNESIUM for an unknown indication. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 23Jan2021 and 2nd dose on 05 Mar 2021). On 06-Mar-2021, the patient experienced ILLNESS (felt sick), HEADACHE (headache), ARTHRALGIA (joint pain), MYALGIA (muscle pain), NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 23Jan2021 and 2nd dose on 05 Mar 2021) outcome was unknown and ILLNESS (felt sick), HEADACHE (headache), ARTHRALGIA (joint pain), MYALGIA (muscle pain), NAUSEA (nausea) and FATIGUE (fatigue) was resolving. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment medications include overt the counter cold pills,allergy pill and advised to take Tylenol by doctor. Action taken with mRNA-1273 in response to the event was not applicable.

Other Meds: LISINOPRIL; HCTZ; FENOFIBRATE; VITAMIN; MAGNESIUM

Current Illness:

ID: 1564660
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: fever; body ache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and PAIN (body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever) and PAIN (body ache). At the time of the report, PYREXIA (fever) and PAIN (body ache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1564661
Sex: M
Age: 81
State: OR

Vax Date: 02/10/2021
Onset Date: 02/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Rashes are itchy; Patient started to have rashes that look like blisters all over his body 2 weeks after first dose; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Rashes are itchy) and RASH (Patient started to have rashes that look like blisters all over his body 2 weeks after first dose) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced RASH PRURITIC (Rashes are itchy) and RASH (Patient started to have rashes that look like blisters all over his body 2 weeks after first dose). At the time of the report, RASH PRURITIC (Rashes are itchy) and RASH (Patient started to have rashes that look like blisters all over his body 2 weeks after first dose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment included Prednisone and a cream

Other Meds:

Current Illness:

ID: 1564662
Sex: F
Age:
State: NM

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: salty taste; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (salty taste) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (salty taste). At the time of the report, DYSGEUSIA (salty taste) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Concomitant medications were not reported. Treatment medications were not mentioned

Other Meds:

Current Illness:

ID: 1564663
Sex: F
Age:
State: TX

Vax Date: 02/27/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: arm is still red; sore to touch like she just got the shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (arm is still red) and VACCINATION SITE PAIN (sore to touch like she just got the shot) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was reported. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (arm is still red) and VACCINATION SITE PAIN (sore to touch like she just got the shot). At the time of the report, VACCINATION SITE ERYTHEMA (arm is still red) and VACCINATION SITE PAIN (sore to touch like she just got the shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication and treatment information were not reported. Patient was not on any medications. Lot number was unknown

Other Meds:

Current Illness:

ID: 1564664
Sex: F
Age: 63
State: CO

Vax Date: 03/09/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Burning eyes and head; Dizziness; Swollen arm , tongue and legs; Swollen arm , tongue and legs; Swollen arm , tongue and legs; the head is tender to touch; woke up at night to drink a lot of water because thought that was dehydrated; Sore throat; The arm is really red; Nausea; Headache; Chattering; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-Mar-2021 and was forwarded to Moderna on 10-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (Burning eyes and head), DIZZINESS (Dizziness), the first episode of PERIPHERAL SWELLING (Swollen arm , tongue and legs), SWOLLEN TONGUE (Swollen arm , tongue and legs) and the second episode of PERIPHERAL SWELLING (Swollen arm , tongue and legs) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced EYE IRRITATION (Burning eyes and head), DIZZINESS (Dizziness), the first episode of PERIPHERAL SWELLING (Swollen arm , tongue and legs), SWOLLEN TONGUE (Swollen arm , tongue and legs), the second episode of PERIPHERAL SWELLING (Swollen arm , tongue and legs), TENDERNESS (the head is tender to touch), DEHYDRATION (woke up at night to drink a lot of water because thought that was dehydrated), OROPHARYNGEAL PAIN (Sore throat), ERYTHEMA (The arm is really red), NAUSEA (Nausea), HEADACHE (Headache) and CHILLS (Chattering). At the time of the report, EYE IRRITATION (Burning eyes and head), DIZZINESS (Dizziness), SWOLLEN TONGUE (Swollen arm , tongue and legs), the last episode of PERIPHERAL SWELLING (Swollen arm , tongue and legs), TENDERNESS (the head is tender to touch), DEHYDRATION (woke up at night to drink a lot of water because thought that was dehydrated), OROPHARYNGEAL PAIN (Sore throat), ERYTHEMA (The arm is really red), NAUSEA (Nausea), HEADACHE (Headache) and CHILLS (Chattering) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1564665
Sex: F
Age: 63
State: TX

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: sore arm; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and FATIGUE (felt tired) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (felt tired). At the time of the report, PAIN IN EXTREMITY (sore arm) and FATIGUE (felt tired) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication details was reported. No treatment medication details was reported.

Other Meds:

Current Illness:

ID: 1564666
Sex: F
Age: 72
State: MD

Vax Date: 02/13/2021
Onset Date: 02/13/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: a 4inch big blister was formed below injection site which is called Bulla; Onset of Migraine; Onset redness belowvaccination site; Onset of mild burning/ache at site of redness. NO itching.; Possible hyper cutaneous sensitivity.; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS ALLERGIC (Possible hyper cutaneous sensitivity.), BLISTER (a 4inch big blister was formed below injection site which is called Bulla), MIGRAINE (Onset of Migraine), VACCINATION SITE ERYTHEMA (Onset redness belowvaccination site) and VACCINATION SITE PAIN (Onset of mild burning/ache at site of redness. NO itching.) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The patient's past medical history included Cholecystectomy in 1994 and Hysterectomy in 1989. Family history included Oculopharyngeal dystrophy. Concurrent medical conditions included Restless leg syndrome since 2000, Migraine headache since 2001, Osteopenia, Hypothyroidism, Asthma, Iron metabolism disorder, Hypotension, Drug allergy (Allergy to sulfa), Drug allergy (Allergy to Tramadol) and Seasonal allergy. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHYROID) for Hypothyroidism, LAMOTRIGINE for Restless leg syndrome. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced DERMATITIS ALLERGIC (Possible hyper cutaneous sensitivity.), MIGRAINE (Onset of Migraine), VACCINATION SITE ERYTHEMA (Onset redness belowvaccination site) and VACCINATION SITE PAIN (Onset of mild burning/ache at site of redness. NO itching.). On 14-Feb-2021, the patient experienced BLISTER (a 4inch big blister was formed below injection site which is called Bulla). The patient was treated with PREDNISONE on 14-Feb-2021 for Adverse event, at a dose of 40 mg once a day; CEPHALEXIN [CEFALEXIN] 14-Feb-2021 for Adverse event, at a dose of 500 mg once a day; CAFFEINE, ERGOTAMINE TARTRATE, METAMIZOLE SODIUM (MIGRANOL [CAFFEINE;ERGOTAMINE TARTRATE;METAMIZOLE SODIUM]) on 13-Feb-2021 for Migraine, at an unspecified dose and frequency; CLOCORTOLONE PIVALATE (topical) on 16-Feb-2021 for Blister, at a dose of 1 dosage form twice a day; PARACETAMOL (TYLENOL) for Pain, at a dose of 1000 mg as required and IBUPROFEN (MOTRIN [IBUPROFEN]) for Pain, at a dose of 800 mg as required. On 14-Feb-2021, MIGRAINE (Onset of Migraine) had resolved. On 19-Feb-2021, BLISTER (a 4inch big blister was formed below injection site which is called Bulla) and VACCINATION SITE PAIN (Onset of mild burning/ache at site of redness. NO itching.) had resolved. On 06-Mar-2021, DERMATITIS ALLERGIC (Possible hyper cutaneous sensitivity.) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Onset redness belowvaccination site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Patient demographics added. Medical history added. Concomitant drugs added. Treatment drugs added. Events added (Migraine, vaccination site pain, vaccination site erythema). Outcome updated.

Other Meds: SYNTHYROID; LAMOTRIGINE

Current Illness: Asthma; Drug allergy (Allergy to Tramadol); Drug allergy (Allergy to sulfa); Hypotension; Hypothyroidism; Iron metabolism disorder; Migraine headache; Osteopenia; Restless leg syndrome; Seasonal allergy

ID: 1564667
Sex: M
Age: 92
State: AZ

Vax Date: 02/25/2021
Onset Date: 03/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Not allergic to shrimp or the vaccination but I'm allergic to both of them together, combo allergy; Eyes and face started to swell up; Swelling under my eye; Welts on my face; Redness; Face was itching; This spontaneous case was reported by a non-health professional (subsequently medically confirmed) and describes the occurrence of DRUG INTERACTION (Not allergic to shrimp or the vaccination but I'm allergic to both of them together, combo allergy), SWELLING FACE (Eyes and face started to swell up), EYE SWELLING (Swelling under my eye), PRURITUS (Face was itching) and URTICARIA (Welts on my face) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No past relevant history was given. Concomitant products included HCTZ, SIMVASTATIN, SAW PALMETTO [SERENOA REPENS], CYANOCOBALAMIN (VITAMIN B 12 [CYANOCOBALAMIN]), COLECALCIFEROL (VITAMIN D 3), MAGNESIUM, METFORMIN, TAMSULOSIN and ASCORBIC ACID, CALCIUM, MINERALS NOS, RETINOL, TOCOPHERYL ACETATE, VITAMIN B NOS, VITAMINS NOS, ZINC (CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]) for an unknown indication. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRURITUS (Face was itching). On 09-Mar-2021, the patient experienced DRUG INTERACTION (Not allergic to shrimp or the vaccination but I'm allergic to both of them together, combo allergy), SWELLING FACE (Eyes and face started to swell up), EYE SWELLING (Swelling under my eye), URTICARIA (Welts on my face) and ERYTHEMA (Redness). On 08-Mar-2021, PRURITUS (Face was itching) had resolved. On 10-Mar-2021, SWELLING FACE (Eyes and face started to swell up), URTICARIA (Welts on my face) and ERYTHEMA (Redness) had resolved. At the time of the report, DRUG INTERACTION (Not allergic to shrimp or the vaccination but I'm allergic to both of them together, combo allergy) outcome was unknown and EYE SWELLING (Swelling under my eye) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment Shot in his hip (doesn't know the name). Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow-up information received on 22-jun-2021 contains no new information.

Other Meds: HCTZ; SIMVASTATIN; SAW PALMETTO [SERENOA REPENS]; VITAMIN B 12 [CYANOCOBALAMIN]; VITAMIN D 3; MAGNESIUM; METFORMIN; TAMSULOSIN; CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS

Current Illness:

ID: 1564668
Sex: M
Age: 34
State: CT

Vax Date: 03/05/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: nauseated; Body aches; Sore arm at injection site; very persistent headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (very persistent headache), NAUSEA (nauseated), MYALGIA (Body aches) and VACCINATION SITE PAIN (Sore arm at injection site) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced MYALGIA (Body aches) and VACCINATION SITE PAIN (Sore arm at injection site). On 10-Mar-2021, the patient experienced NAUSEA (nauseated). In March 2021, the patient experienced HEADACHE (very persistent headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 07-Mar-2021, MYALGIA (Body aches) and VACCINATION SITE PAIN (Sore arm at injection site) had resolved. At the time of the report, HEADACHE (very persistent headache) and NAUSEA (nauseated) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: ADDERALL

Current Illness:

ID: 1564669
Sex: M
Age: 29
State: OH

Vax Date: 02/25/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: patient was given 2nd dose of the vaccine 14 days after the 1st dose; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient was given 2nd dose of the vaccine 14 days after the 1st dose) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient was given 2nd dose of the vaccine 14 days after the 1st dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient was given 2nd dose of the vaccine 14 days after the 1st dose) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medication details was reported. Action taken with mRNA-1273 in response to the events was not applicable.

Other Meds: CARBATROL; ADDERALL; RISPERIDONE; ZOLOFT

Current Illness:

ID: 1564670
Sex: F
Age: 21
State: ME

Vax Date: 01/08/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: test was false positive; tested positive from a rapid PCR test; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive from a rapid PCR test) and SARS-COV-2 TEST FALSE POSITIVE (test was false positive) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included COVID-19 on 11-Nov-2020. On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive from a rapid PCR test). On an unknown date, the patient experienced SARS-COV-2 TEST FALSE POSITIVE (test was false positive). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive from a rapid PCR test) and SARS-COV-2 TEST FALSE POSITIVE (test was false positive) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, SARS-CoV-2 test: positive (Positive) positive. No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to events was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow-up information received on 21-JUN-2021 and event (SARS COV-2 test false positive) is updated

Other Meds:

Current Illness:

ID: 1564671
Sex: F
Age: 69
State: MA

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Fall with injury to the face requiring one stitch; Headache; Light headed/Dizzy; More off balance than usual; Caller is calling to update contact information

Other Meds: ALDACTONE 50 HCT; XANAX; LEXAPRO; BROMELAIN

Current Illness: Charcot-Marie-Tooth disease (normally makes her a little off balance)

ID: 1564672
Sex: F
Age:
State:

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: a lot worse and heavier than her normal periods; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUAL DISORDER (a lot worse and heavier than her normal periods) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced MENSTRUAL DISORDER (a lot worse and heavier than her normal periods). At the time of the report, MENSTRUAL DISORDER (a lot worse and heavier than her normal periods) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication details was reported. No treatment medication details was reported.

Other Meds:

Current Illness:

ID: 1564673
Sex: F
Age: 79
State: NY

Vax Date: 02/26/2021
Onset Date: 03/07/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Warmth of skin at injection site in the left upper arm; Itching at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warmth of skin at injection site in the left upper arm) and VACCINATION SITE PRURITUS (Itching at injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN and VITAMINS NOS for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warmth of skin at injection site in the left upper arm) and VACCINATION SITE PRURITUS (Itching at injection site). At the time of the report, VACCINATION SITE WARMTH (Warmth of skin at injection site in the left upper arm) and VACCINATION SITE PRURITUS (Itching at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medication details was reported.

Other Meds: ATORVASTATIN; VITAMINS NOS

Current Illness:

ID: 1564674
Sex: F
Age: 62
State: FL

Vax Date: 01/09/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: sleeplessness; This spontaneous case was reported by a health care professional and describes the occurrence of INSOMNIA (sleeplessness) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Irritable bowel syndrome. On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (sleeplessness). At the time of the report, INSOMNIA (sleeplessness) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication details was reported. No treatment medication details was reported. This case was linked to MOD21-050421 (Patient Link).

Other Meds:

Current Illness:

ID: 1564675
Sex: F
Age: 71
State: WA

Vax Date: 02/28/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: rash on arm at the vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash on arm at the vaccination site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash on arm at the vaccination site). At the time of the report, VACCINATION SITE RASH (rash on arm at the vaccination site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication details was reported. No treatment medication details was reported.

Other Meds:

Current Illness:

ID: 1564676
Sex: F
Age: 69
State: AL

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Tongue is swollen; Throat is swollen; Tongue feels numb; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (Tongue is swollen), PHARYNGEAL SWELLING (Throat is swollen) and HYPOAESTHESIA ORAL (Tongue feels numb) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 127721A) for COVID-19 vaccination. No Medical History information was reported. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced SWOLLEN TONGUE (Tongue is swollen), PHARYNGEAL SWELLING (Throat is swollen) and HYPOAESTHESIA ORAL (Tongue feels numb). At the time of the report, SWOLLEN TONGUE (Tongue is swollen), PHARYNGEAL SWELLING (Throat is swollen) and HYPOAESTHESIA ORAL (Tongue feels numb) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications included diabetic medication and blood pressure medication. No treatment medication was reported.

Other Meds:

Current Illness:

ID: 1564677
Sex: F
Age: 37
State: NC

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: itching; pain at injection site left arm; rash; heat; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (heat), VACCINATION SITE PRURITUS (itching), VACCINATION SITE PAIN (pain at injection site left arm) and VACCINATION SITE RASH (rash) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. No Medical History information was reported. On 08-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE WARMTH (heat) and VACCINATION SITE RASH (rash). On 09-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itching) and VACCINATION SITE PAIN (pain at injection site left arm). At the time of the report, VACCINATION SITE WARMTH (heat), VACCINATION SITE PRURITUS (itching), VACCINATION SITE PAIN (pain at injection site left arm) and VACCINATION SITE RASH (rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was reported. The treatment medication included patient applied cream twice.

Other Meds:

Current Illness:

ID: 1564678
Sex: F
Age: 40
State: TX

Vax Date: 03/08/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: soreness under her arm pit; Huge swollen lymph node; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (soreness under her arm pit) and LYMPHADENOPATHY (Huge swollen lymph node) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. No Medical History information was reported. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced AXILLARY PAIN (soreness under her arm pit) and LYMPHADENOPATHY (Huge swollen lymph node). At the time of the report, AXILLARY PAIN (soreness under her arm pit) and LYMPHADENOPATHY (Huge swollen lymph node) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication details was reported. No treatment medication details was reported.

Other Meds:

Current Illness:

ID: 1564679
Sex: F
Age: 73
State: TX

Vax Date: 01/29/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Sore arm; fatigue; little tired; feeling achy; Covid arm; a rash that is warm ,red, and itchy; a rash that is warm ,red, and itchy; a rash that is warm ,red, and itchy; second dose on 4Mar2021 in my right arm which is a 34 days difference.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), SKIN WARM (a rash that is warm ,red, and itchy), FATIGUE (fatigue), ERYTHEMA (a rash that is warm ,red, and itchy) and FATIGUE (little tired) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose on 4Mar2021 in my right arm which is a 34 days difference.). On 09-Mar-2021, the patient experienced SKIN WARM (a rash that is warm ,red, and itchy), ERYTHEMA (a rash that is warm ,red, and itchy), COVID-19 (Covid arm) and PRURITUS (a rash that is warm ,red, and itchy). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). an unknown date, the patient experienced FATIGUE (fatigue), FATIGUE (little tired) and PAIN (feeling achy). On 04-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose on 4Mar2021 in my right arm which is a 34 days difference.) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm), SKIN WARM (a rash that is warm ,red, and itchy), FATIGUE (fatigue), ERYTHEMA (a rash that is warm ,red, and itchy), FATIGUE (little tired), PAIN (feeling achy), COVID-19 (Covid arm) and PRURITUS (a rash that is warm ,red, and itchy) outcome was unknown. Not Provided No relevant concomitant medications provided. No relevant Treatment information provided. Action taken with mRNA-1273 in response to the events was not applicable.

Other Meds:

Current Illness:

ID: 1564680
Sex: M
Age: 78
State: FL

Vax Date: 01/27/2021
Onset Date: 02/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Burning sensation skin; a series of rashes on the back of my hands, fingers, ankles ,lower wrist and forearm; This spontaneous case was reported by a consumer and describes the occurrence of SKIN BURNING SENSATION (Burning sensation skin) and RASH (a series of rashes on the back of my hands, fingers, ankles ,lower wrist and forearm) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 029K20A) for COVID-19 vaccination. No past medical history was provided. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced SKIN BURNING SENSATION (Burning sensation skin) and RASH (a series of rashes on the back of my hands, fingers, ankles ,lower wrist and forearm). At the time of the report, SKIN BURNING SENSATION (Burning sensation skin) outcome was unknown and RASH (a series of rashes on the back of my hands, fingers, ankles ,lower wrist and forearm) had not resolved. No concomitant medication was reported. Treatment information was included topical cream prescribed by dermatologist for a week. Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Non-significant follow up appended

Other Meds:

Current Illness:

ID: 1564681
Sex: F
Age: 72
State: MI

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: right arm was red; right arm felt hot; right arm felt swollen; soreness in her right arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in her right arm), PERIPHERAL SWELLING (right arm felt swollen), ERYTHEMA (right arm was red) and FEELING HOT (right arm felt hot) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness in her right arm). On 06-Mar-2021, the patient experienced PERIPHERAL SWELLING (right arm felt swollen). On 10-Mar-2021, the patient experienced ERYTHEMA (right arm was red) and FEELING HOT (right arm felt hot). On 26-Feb-2021, PAIN IN EXTREMITY (soreness in her right arm) had resolved. At the time of the report, PERIPHERAL SWELLING (right arm felt swollen), ERYTHEMA (right arm was red) and FEELING HOT (right arm felt hot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication details was reported. No treatment medication details was reported.

Other Meds:

Current Illness:

ID: 1564682
Sex: M
Age: 68
State: MN

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Fatigue; involuntary muscle movement on left middle forearm on the pinkie side down by his wrist, felt like a thump thump (not muscle but nerve); diarrhea; felt cold; nerve reaction; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), DYSKINESIA (involuntary muscle movement on left middle forearm on the pinkie side down by his wrist, felt like a thump thump (not muscle but nerve)), DIARRHOEA (diarrhea), FEELING COLD (felt cold) and NEUROLOGICAL SYMPTOM (nerve reaction) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE, ATORVASTATIN, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ), ACETYLSALICYLIC ACID (ASPIRIN 81) and NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) for an unknown indication. On 08-Mar-2021 at 6:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced FATIGUE (Fatigue), DYSKINESIA (involuntary muscle movement on left middle forearm on the pinkie side down by his wrist, felt like a thump thump (not muscle but nerve)), DIARRHOEA (diarrhea), FEELING COLD (felt cold) and NEUROLOGICAL SYMPTOM (nerve reaction). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-Mar-2021, FATIGUE (Fatigue), DIARRHOEA (diarrhea) and FEELING COLD (felt cold) had resolved. On 09-Mar-2021, DYSKINESIA (involuntary muscle movement on left middle forearm on the pinkie side down by his wrist, felt like a thump thump (not muscle but nerve)) and NEUROLOGICAL SYMPTOM (nerve reaction) had resolved. Not Provided

Other Meds: AMLODIPINE; ATORVASTATIN; LOSARTAN HCTZ; ASPIRIN 81; BYSTOLIC

Current Illness:

ID: 1564683
Sex: F
Age:
State: OH

Vax Date: 01/26/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Patient did not receive the second dose with in 42 days after the first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of OFF LABEL USE (Patient did not receive the second dose with in 42 days after the first dose) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OFF LABEL USE (Patient did not receive the second dose with in 42 days after the first dose). At the time of the report, OFF LABEL USE (Patient did not receive the second dose with in 42 days after the first dose) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were provided by the reporter.

Other Meds:

Current Illness:

ID: 1564684
Sex: F
Age: 61
State: NM

Vax Date: 02/10/2021
Onset Date: 02/20/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Red Welt; Red Circle diameter is 4inches does not hurt/Outer ring of Red circle is a darker red ring; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Red Welt) and ERYTHEMA (Red Circle diameter is 4inches does not hurt/Outer ring of Red circle is a darker red ring) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced URTICARIA (Red Welt) and ERYTHEMA (Red Circle diameter is 4inches does not hurt/Outer ring of Red circle is a darker red ring). At the time of the report, URTICARIA (Red Welt) and ERYTHEMA (Red Circle diameter is 4inches does not hurt/Outer ring of Red circle is a darker red ring) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant information use was not reported. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1564685
Sex: M
Age:
State: FL

Vax Date: 02/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: chills; muscle soreness; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and MYALGIA (muscle soreness) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A20A and 031L20A) for COVID-19 vaccination. Concomitant products included ATORVASTATIN, LISINOPRIL and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced CHILLS (chills) and MYALGIA (muscle soreness). At the time of the report, CHILLS (chills) and MYALGIA (muscle soreness) outcome was unknown. No treatment medications were provided by the reporter.

Other Meds: ATORVASTATIN; LISINOPRIL; BABY ASPIRIN

Current Illness:

ID: 1564686
Sex: F
Age: 62
State: FL

Vax Date: 01/09/2021
Onset Date: 02/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: arm pain; malaise; Fever; banging headache; gastric upset; abdomen has been swollen; appetite has been suppressed/ significant reduced appetite/ slight anorexia; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (arm pain), ABDOMINAL DISTENSION (abdomen has been swollen), DECREASED APPETITE (appetite has been suppressed/ significant reduced appetite/ slight anorexia), MALAISE (malaise) and ABDOMINAL DISCOMFORT (gastric upset) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Irritable bowel syndrome. Concurrent medical conditions included Allergy to antibiotic (minocycline). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication. On 09-Jan-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced ABDOMINAL DISTENSION (abdomen has been swollen), DECREASED APPETITE (appetite has been suppressed/ significant reduced appetite/ slight anorexia) and ABDOMINAL DISCOMFORT (gastric upset). On an unknown date, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (arm pain), MALAISE (malaise), PYREXIA (Fever) and HEADACHE (banging headache). In March 2021, ABDOMINAL DISTENSION (abdomen has been swollen), DECREASED APPETITE (appetite has been suppressed/ significant reduced appetite/ slight anorexia) and ABDOMINAL DISCOMFORT (gastric upset) had resolved. At the time of the report, PAIN IN EXTREMITY (arm pain), MALAISE (malaise), PYREXIA (Fever) and HEADACHE (banging headache) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medications were provided by the reporter. This case was linked to MOD21-050421 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: No specific follow-up information recorded.

Other Meds: CRESTOR

Current Illness: Allergy to antibiotic (minocycline)

ID: 1564687
Sex: F
Age: 70
State: WA

Vax Date: 02/04/2021
Onset Date: 03/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (generally miserable), DIZZINESS (she is lightheaded), PAIN IN EXTREMITY (she has had a sore arm), HEADACHE (really a bad headache/ periodically a headache on left side of her head) and VACCINATION SITE PAIN (she still feels a burning pain on her left arm (injection site)) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Thyroid disorder NOS (Thyroid shut down). Previously administered products included for COVID-19: Augmentin (She claims that the Augmentin that she was prescribed with during that time screwed up her guts) in February 2020. Past adverse reactions to the above products included Abdominal disorder with Augmentin. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced FEELING ABNORMAL (generally miserable), HEADACHE (really a bad headache/ periodically a headache on left side of her head) and ARTHRALGIA (joint aches). On 10-Mar-2021, the patient experienced DIZZINESS (she is lightheaded) and PAIN IN EXTREMITY (she has had a sore arm). On an unknown date, the patient experienced VACCINATION SITE PAIN (she still feels a burning pain on her left arm (injection site)). At the time of the report, FEELING ABNORMAL (generally miserable), DIZZINESS (she is lightheaded), PAIN IN EXTREMITY (she has had a sore arm), HEADACHE (really a bad headache/ periodically a headache on left side of her head) and ARTHRALGIA (joint aches) outcome was unknown and VACCINATION SITE PAIN (she still feels a burning pain on her left arm (injection site)) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Body temperature: 100.5 f High. No concomitant medications were reported. No treatment medications were provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Updated patient demographics, medical history and added new event.

Other Meds:

Current Illness:

ID: 1564688
Sex: F
Age: 89
State: WI

Vax Date: 02/12/2021
Onset Date: 03/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Dry mouth; sore arm; redness; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth), PAIN IN EXTREMITY (sore arm) and ERYTHEMA (redness) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included GABAPENTIN for an unknown indication. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced DRY MOUTH (Dry mouth), PAIN IN EXTREMITY (sore arm) and ERYTHEMA (redness). At the time of the report, DRY MOUTH (Dry mouth), PAIN IN EXTREMITY (sore arm) and ERYTHEMA (redness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For treatment, patient used over the counter muscle rub and some biotin contain wash for topical use.

Other Meds: GABAPENTIN

Current Illness:

ID: 1564689
Sex: F
Age: 68
State: NY

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: She developed a hot rash in it below injection site; She developed a hot rash fever in it below injection site; Headache; Legs were very stiff; States that she had to crawl up the stairs; Chest congestion; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Legs were very stiff), GAIT INABILITY (States that she had to crawl up the stairs), CHEST DISCOMFORT (Chest congestion), VACCINATION SITE RASH (She developed a hot rash in it below injection site) and VACCINATION SITE WARMTH (She developed a hot rash fever in it below injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Legs were very stiff), GAIT INABILITY (States that she had to crawl up the stairs), CHEST DISCOMFORT (Chest congestion) and HEADACHE (Headache). On 10-Mar-2021, the patient experienced VACCINATION SITE RASH (She developed a hot rash in it below injection site) and VACCINATION SITE WARMTH (She developed a hot rash fever in it below injection site). At the time of the report, MUSCULOSKELETAL STIFFNESS (Legs were very stiff), GAIT INABILITY (States that she had to crawl up the stairs), CHEST DISCOMFORT (Chest congestion), VACCINATION SITE RASH (She developed a hot rash in it below injection site), VACCINATION SITE WARMTH (She developed a hot rash fever in it below injection site) and HEADACHE (Headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: up to 102.5 up to 102.5. No concomitant medications were reported. No treatment medications were provided by the reporter.

Other Meds:

Current Illness:

ID: 1564690
Sex: F
Age: 57
State: OR

Vax Date: 03/09/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Chills; This spontaneous case was reported by a patient and describes the occurrence of CHILLS (Chills) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0ZA21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced CHILLS (Chills). On 10-Mar-2021 at 5:00 AM, CHILLS (Chills) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications included natural pills. Treatment information was was not provided.

Other Meds:

Current Illness:

ID: 1564691
Sex: F
Age:
State: CA

Vax Date: 03/07/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: injection site very swollen; injection site very red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (injection site very swollen) and INJECTION SITE ERYTHEMA (injection site very red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 07-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE SWELLING (injection site very swollen) and INJECTION SITE ERYTHEMA (injection site very red). At the time of the report, INJECTION SITE SWELLING (injection site very swollen) and INJECTION SITE ERYTHEMA (injection site very red) outcome was unknown. No concomitant medications were reported. No treatment medications were provided by the reporter.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm